In the context of T1D, an autoimmune disease characterized by T-cell-mediated destruction of insulin-producing β-cells [2], potassium dysregulation could influence immune responses or β-cell vulnerability, potentially contributing to disease risk. The gene discussed is INS; the disease is autoimmune disease.